LY2811376 is the first orally available non-peptidic β-secretase ( BACE1 ) inhibitor with IC 50 of 239 nM-249 nM, that acts to decrease Aβ secretion with EC 50 of 300 nM, and demonstrates to have 10-fold selectivity towards BACE1 over BACE2 , and more than 50-fold inhibition over other aspartic proteases including cathepsin D , pepsin, or renin .
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Beta-secretase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.